Literature DB >> 19429508

Understanding nuclear receptors using computational methods.

Ni Ai1, Matthew D Krasowski, William J Welsh, Sean Ekins.   

Abstract

Nuclear receptors (NRs) are important targets for therapeutic drugs. NRs regulate transcriptional activities through binding to ligands and interacting with several regulating proteins. Computational methods can provide insights into essential ligand-receptor and protein-protein interactions. These in turn have facilitated the discovery of novel agonists and antagonists with high affinity and specificity as well as have aided in the prediction of toxic side effects of drugs by identifying possible off-target interactions. Here, we review the application of computational methods toward several clinically important NRs (with special emphasis on PXR) and discuss their use for screening and predicting the toxic side effects of xenobiotics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429508      PMCID: PMC2846174          DOI: 10.1016/j.drudis.2009.03.003

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  90 in total

Review 1.  Flexible nets. The roles of intrinsic disorder in protein interaction networks.

Authors:  A Keith Dunker; Marc S Cortese; Pedro Romero; Lilia M Iakoucheva; Vladimir N Uversky
Journal:  FEBS J       Date:  2005-10       Impact factor: 5.542

2.  Considerations in compound database preparation--"hidden" impact on virtual screening results.

Authors:  Andrew J S Knox; Mary J Meegan; Giorgio Carta; David G Lloyd
Journal:  J Chem Inf Model       Date:  2005 Nov-Dec       Impact factor: 4.956

3.  Conservation of intrinsic disorder in protein domains and families: II. functions of conserved disorder.

Authors:  Jessica Walton Chen; Pedro Romero; Vladimir N Uversky; A Keith Dunker
Journal:  J Proteome Res       Date:  2006-04       Impact factor: 4.466

4.  Molecular dynamics simulations of ligand dissociation from thyroid hormone receptors: evidence of the likeliest escape pathway and its implications for the design of novel ligands.

Authors:  Leandro Martínez; Paul Webb; Igor Polikarpov; Munir S Skaf
Journal:  J Med Chem       Date:  2006-01-12       Impact factor: 7.446

5.  Evolution of the pregnane x receptor: adaptation to cross-species differences in biliary bile salts.

Authors:  Matthew D Krasowski; Kazuto Yasuda; Lee R Hagey; Erin G Schuetz
Journal:  Mol Endocrinol       Date:  2005-02-17

6.  Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activities.

Authors:  I-Lin Lu; Chien-Fu Huang; Yi-Hui Peng; Ying-Ting Lin; Hsing-Pang Hsieh; Chiung-Tong Chen; Tzu-Wen Lien; Hwei-Jen Lee; Neeraj Mahindroo; Ekambaranellore Prakash; Andrew Yueh; Hsin-Yi Chen; Chandra M V Goparaju; Xin Chen; Chun-Chen Liao; Yu-Sheng Chao; John T-A Hsu; Su-Ying Wu
Journal:  J Med Chem       Date:  2006-05-04       Impact factor: 7.446

7.  Structural model reveals key interactions in the assembly of the pregnane X receptor/corepressor complex.

Authors:  Ching Y Wang; Chia W Li; J Don Chen; William J Welsh
Journal:  Mol Pharmacol       Date:  2006-02-01       Impact factor: 4.436

8.  Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.

Authors:  Youssef A Elhaji; Ileana Stoica; Sheldon Dennis; Enrico O Purisima; Rose Lumbroso; Lenore K Beitel; Mark A Trifiro
Journal:  Hum Mol Genet       Date:  2006-01-31       Impact factor: 6.150

9.  Molecular dynamics simulations reveal multiple pathways of ligand dissociation from thyroid hormone receptors.

Authors:  Leandro Martínez; Milton T Sonoda; Paul Webb; John D Baxter; Munir S Skaf; Igor Polikarpov
Journal:  Biophys J       Date:  2005-06-24       Impact factor: 4.033

Review 10.  Estrogen receptors: molecular interactions, virtual screening and future prospects.

Authors:  Andrew J S Knox; Mary J Meegan; David G Lloyd
Journal:  Curr Top Med Chem       Date:  2006       Impact factor: 3.295

View more
  8 in total

Review 1.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

2.  Evolution of promiscuous nuclear hormone receptors: LXR, FXR, VDR, PXR, and CAR.

Authors:  Matthew D Krasowski; Ai Ni; Lee R Hagey; Sean Ekins
Journal:  Mol Cell Endocrinol       Date:  2010-07-06       Impact factor: 4.102

3.  Proteomic mechanisms of cardioprotection during mammalian hibernation in woodchucks, Marmota monax.

Authors:  Hong Li; Tong Liu; Wei Chen; Mohit Raja Jain; Dorothy E Vatner; Stephen F Vatner; Raymond K Kudej; Lin Yan
Journal:  J Proteome Res       Date:  2013-08-06       Impact factor: 4.466

4.  Role of nuclear receptors in lipid dysfunction and obesity-related diseases.

Authors:  Hollie I Swanson; Taira Wada; Wen Xie; Barbara Renga; Angela Zampella; Eleonora Distrutti; Stefano Fiorucci; Bo Kong; Ann M Thomas; Grace L Guo; Ramesh Narayanan; Muralimohan Yepuru; James T Dalton; John Y L Chiang
Journal:  Drug Metab Dispos       Date:  2012-10-04       Impact factor: 3.922

5.  Agonist and antagonist binding to the nuclear vitamin D receptor: dynamics, mutation effects and functional implications.

Authors:  Sepideh Yaghmaei; Christopher Roberts; Rizi Ai; Mathew T Mizwicki; Chia-En A Chang
Journal:  In Silico Pharmacol       Date:  2013-02-12

6.  Discrepancy in interactions and conformational dynamics of pregnane X receptor (PXR) bound to an agonist and a novel competitive antagonist.

Authors:  Azam Rashidian; Enni-Kaisa Mustonen; Thales Kronenberger; Matthias Schwab; Oliver Burk; Stefan A Laufer; Tatu Pantsar
Journal:  Comput Struct Biotechnol J       Date:  2022-06-13       Impact factor: 6.155

7.  Insight into glucocorticoid receptor signalling through interactome model analysis.

Authors:  Emyr Bakker; Kun Tian; Luciano Mutti; Constantinos Demonacos; Jean-Marc Schwartz; Marija Krstic-Demonacos
Journal:  PLoS Comput Biol       Date:  2017-11-06       Impact factor: 4.475

8.  Exploring the PXR ligand binding mechanism with advanced Molecular Dynamics methods.

Authors:  Stefano Motta; Lara Callea; Sara Giani Tagliabue; Laura Bonati
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.